National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 51606-51607 [2019-21055]

Download as PDF 51606 Federal Register / Vol. 84, No. 189 / Monday, September 30, 2019 / Notices ESTIMATED ANNUALIZED BURDEN TABLE—Continued Total burden hours 45 CFR 164.520 Notice of Privacy Practices for Protected Health Information (health plans—periodic distribution of NPPs by paper mail). 45 CFR 164.520 Notice of Privacy Practices for Protected Health Information (health plans—periodic distribution of NPPs by electronic mail). 45 CFR 164.520 Notice of Privacy Practices for Protected Health Information (health care providers—dissemination and acknowledgement). 45 CFR 164.522 Rights to Request Privacy Protection for Protected Health Information. 45 CFR 164.524 Access of Individuals to Protected Health Information (disclosures). 45 CFR 164.526 Amendment of Protected Health Information (requests). Covered entities—health plans 100,000,000 1 0.004166667 416,667 Covered entities—health plans 100,000,000 1 0.002783333 278,333 Covered entities—health care providers. 613,000,000 1 0.05 30,650,000 Covered entities—health care providers, health plans. 20,000 1 0.05 1,000 Covered entities—health care providers, health plans, clearinghouses. Covered entities—health care providers, health plans, clearinghouses. Covered entities—health care providers, health plans, clearinghouses. Covered entities—health care providers, health plans, clearinghouses. 200,000 1 0.05 10,000 150,000 1 0.083333333 12,500 50,000 1 0.083333333 4,167 5,000 1 0.05 250 ........................ ........................ ........................ 921,158,941 45 CFR 164.528 Accounting for Disclosures of Protected Health Information. Total ................................................... .................................................. Debbie Kramer, HHS Information Collection Reports Clearance Officer. [FR Doc. 2019–21031 Filed 9–27–19; 8:45 am] BILLING CODE 4153–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders & Stroke (NINDS); Notice of Organizational Change AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institute of Neurological Disorders and Stroke (NINDS) will launch a public information website and host a webinar to enable public discussion regarding NINDS proposal to reorganize the Office of Communications and Public Liaison and Office of Scientific Liaison. DATES: NINDS will launch public website information at https:// www.ninds.nih.gov/About-NINDS/ Public-Hearing-NINDS-OfficeNeuroscience-Communications-andEngagement-Proposal on October 01, 2019. A public webinar will be held on SUMMARY: VerDate Sep<11>2014 19:16 Sep 27, 2019 Jkt 247001 Number of respondents Average burden per response Respondents (if necessary) 45 CFR 164.526 Amendment of Protected Health Information (denials). khammond on DSKJM1Z7X2PROD with NOTICES Number of responses per respondents Forms (if necessary) October 17, 2019 at 1:00 p.m. EST. A recording of the webinar will be posted no later than October 18, 2019 at 3:00 p.m. EST. Any interested person may file written comments by sending an email to NINDSReorgComments@ nih.gov by October 31, 2019. The statement should include the individual’s name, and when applicable, professional affiliation. NINDS will respond to comments by email no later than November 07, 2019. ADDRESSES: The following email address has been established for questions and/ or comments on the reorganization: NINDSReorgComments@nih.gov. FOR FURTHER INFORMATION CONTACT: Mary Coats, Management Analyst, National Institute of Neurological Disorders & Stroke (NINDS), NINDSReorgComments@nih.gov, 301– 594–4489. SUPPLEMENTARY INFORMATION: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. Sec. 281 (d)(4)), NINDS will launch a public information website at https://www.ninds.nih.gov/AboutNINDS/Public-Hearing-NINDS-OfficeNeuroscience-Communications-andEngagement-Proposal and host a webinar to enable public discussion regarding NINDS proposal to reorganize the Office of Communications and Public Liaison and Office of Scientific PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 Liaison. Details of the reorganization and information regarding the webinar is available on the Institute’s website at https://www.ninds.nih.gov/AboutNINDS/Public-Hearing-NINDS-OfficeNeuroscience-Communications-andEngagement-Proposal. This reorganization will support efforts to Optimize NIH as it will foster greater collaboration and sharing of resources across NINDS. Dated: September 19, 2019. Walter J. Koroshetz, Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health. [FR Doc. 2019–21189 Filed 9–27–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., E:\FR\FM\30SEN1.SGM 30SEN1 Federal Register / Vol. 84, No. 189 / Monday, September 30, 2019 / Notices as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Clinical and Basic Science Review Committee, NHLBI ‘‘Mentored Clinical and Basic Science Review Committee’’ MCBS. Date: November 7–8, 2019. Time: 10:30 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza National Airport, 1480 Crystal Drive, Arlington, MD 22202. Contact Person: Keith A. Mintzer, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD 20892–7924, 301–827– 7949, mintzerk@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: September 24, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Natalia Komissarova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD 20892, 301–435– 1206, komissar@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–AI19– 022: US-South Africa Program for Collaborative HIV/AIDS Biomedical Research. Date: October 25, 2019. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shalanda A. Bynum, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301–755–4355, bynumsa@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) [FR Doc. 2019–21055 Filed 9–27–19; 8:45 am] Dated: September 23, 2019. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P [FR Doc. 2019–21056 Filed 9–27–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Vascular and Hematology Integrated Review Group; Atherosclerosis and Inflammation of the Cardiovascular System Study Section. Date: October 17–18, 2019. VerDate Sep<11>2014 19:16 Sep 27, 2019 Jkt 247001 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Diseases and Pathophysiology of the Visual System Study Section. PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 51607 Date: October 28–29, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites—Chevy Chase Pavilion 4300 Military Road NW, Washington, DC 20015. Contact Person: Nataliya Gordiyenko, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD 20892, 301.435.1265, gordiyenkon@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Acute Neural Injury and Epilepsy Study Section. Date: October 28–29, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance, Washington, DC Hotel, 999 Ninth Street NW, Washington, DC 20001–4427. Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301–760–8207, schauweckerpe@csr.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Radiation Therapeutics and Biology Study Section. Date: October 28–29, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Bo Hong, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301–996–6208, hongb@csr.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Cancer, Heart, and Sleep Epidemiology B Study Section. Date: October 28–29, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC 20037. Contact Person: Gniesha Yvonne Dinwiddie, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3137, Bethesda, MD 20892, 301–827– 7235, dinwiddiegy@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Clinical Management of Patients in Community-based Settings Study Section. Date: October 28–29, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: InterContinental Chicago Hotel, 505 North Michigan Avenue, Chicago, IL 60611. Contact Person: Lauren Fordyce, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of E:\FR\FM\30SEN1.SGM 30SEN1

Agencies

[Federal Register Volume 84, Number 189 (Monday, September 30, 2019)]
[Notices]
[Pages 51606-51607]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21055]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting. The meeting 
will be closed to the public in accordance with the provisions set 
forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

[[Page 51607]]

as amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group; 
NHLBI Mentored Clinical and Basic Science Review Committee, NHLBI 
``Mentored Clinical and Basic Science Review Committee'' MCBS.
    Date: November 7-8, 2019.
    Time: 10:30 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza National Airport, 1480 Crystal Drive, 
Arlington, MD 22202.
    Contact Person: Keith A. Mintzer, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD 
20892-7924, 301-827-7949, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 24, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-21055 Filed 9-27-19; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.